Clinical Trial: Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC)

Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (SN-FNAC)

Sponsor and Collaborators
Centre hospitalier de l'Université de Montréal (CHUM)

Contact
Contact: Nicole Tremblay, Ph.D.
514-890-8000 ext 15535
nicole.g.tremblay.chum@ssss.gouv.qc.ca

Contact: Ana Lydia Tkalec, B.Sc.
514-890-8000 ext 14186
ana.lydia.tkalec.chum@ssss.gouv.qc.ca

Locations
Canada, Quebec
Centre de recherche du Centre hospitalier de l'Université de Montréal Montréal, Quebec, Canada, H2W 1T7

Principal Investigator
Jean-François Boileau, MD FRCSC
Centre Hospitalier de l'Université de Montréal

ClinicalTrials.gov Identifier
NCT00909441
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs